Literature DB >> 18466867

Extensive hilar bile duct resection using a transhepatic approach for patients with hepatic hilar bile duct diseases.

Masaru Miyazaki1, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Otsuka, Atsushi Kato, Yoshitomi Hideyuki, Satoshi Nozawa, Katsunori Furukawa, Noboru Mituhashi, Dan Takeuchi, Kousuke Suda, Shigetsugu Takano.   

Abstract

BACKGROUND: Extensive hilar bile duct resection beyond the second- or third-order intrahepatic biliary radicals is usually required for patients with hilar cholangiocarcinoma as well as those with benign inflammatory stricture. Most hilar cholangiocarcinoma is resected with combined major hepatectomy to obtain free surgical margins. The purpose of this study was to show the surgical procedure and the usefulness of extensive hilar bile duct resection using a transhepatic approach for patients with hilar bile duct diseases.
METHODS: Five patients with hepatic hilar bile duct disease and who were unfit for major hepatectomy for several reasons underwent extensive hilar bile duct resection by way of a transhepatic approach. Four of the patients had hilar bile duct cancer, including 1 with mucous-producing bile duct cancer of low-grade malignancy and 1 with a postsurgical benign bile duct stricture.
RESULTS: After extensive hilar bile duct resection, bile duct stumps ranged in number from 3 to 7 mm (mean 4.4). Surgical margins at bile duct stump were free of cancer in all 4 cancer patients. The long-term outcomes were as follows: 3 patients are alive at the time of publication, and 2 patients have died.
CONCLUSIONS: A transhepatic approach may be useful when performing extensive hilar bile duct resection bile duct stricture of biliary disease at the hepatic hilus, especially in high-risk patients who are unfit for major hepatectomy as well as in those having benign bile duct stricture and low-grade malignancy.

Entities:  

Mesh:

Year:  2008        PMID: 18466867     DOI: 10.1016/j.amjsurg.2007.04.020

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

1.  Role of Kasai procedure in surgery of hilar bile duct strictures.

Authors:  Jin-Bo Gao; Li-Shan Bai; Zhi-Jian Hu; Jun-Wei Wu; Xin-Qun Chai
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer.

Authors:  Tsuyoshi Sano; Yasuhiro Shimizu; Yoshiki Senda; Koji Komori; Seiji Ito; Tetsuya Abe; Taira Kinoshita; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2013-09-13       Impact factor: 3.445

3.  Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinoma.

Authors:  Zheng Shi; Ming-Zhi Yang; Qing-Liang He; Rong-Wen Ou; You-Ting Chen
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

4.  Issues in surgery for hilar cholangiocarcinoma.

Authors:  Sudeep R Shah
Journal:  Indian J Surg       Date:  2011-11-29       Impact factor: 0.656

5.  Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.

Authors:  Xinsen Xu; Linhua Yang; Wei Chen; Min He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.

Authors:  Naohisa Kuriyama; Shuji Isaji; Akihiro Tanemura; Yusuke Iizawa; Hiroyuki Kato; Yasuhiro Murata; Yoshinori Azumi; Masashi Kishiwada; Shugo Mizuno; Masanobu Usui; Hiroyuki Sakurai
Journal:  J Gastrointest Surg       Date:  2016-11-28       Impact factor: 3.452

7.  Preoperative Bilirubin Level Predicts Overall Survival and Tumor Recurrence After Resection for Perihilar Cholangiocarcinoma Patients.

Authors:  Chang Xian Li; Hui Zhang; Ke Wang; Xuehao Wang; Xiang Cheng Li
Journal:  Cancer Manag Res       Date:  2019-12-02       Impact factor: 3.989

8.  A case of pancreaticoduodenectomy and partial hepatic resection as repeat cytoreductive surgery for recurrent pseudomyxoma peritonei.

Authors:  Kenya Yamanaka; Norishige Iizuka; Toshiyuki Kitai
Journal:  Surg Case Rep       Date:  2021-12-04

Review 9.  Intraductal papillary neoplasms of the bile duct.

Authors:  Masayuki Ohtsuka; Hiroaki Shimizu; Atsushi Kato; Hideyuki Yoshitomi; Katsunori Furukawa; Toshio Tsuyuguchi; Yuji Sakai; Osamu Yokosuka; Masaru Miyazaki
Journal:  Int J Hepatol       Date:  2014-05-18

10.  Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.

Authors:  Naohisa Kuriyama; Masanobu Usui; Kazuaki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Hiroyuki Kato; Yasuhiro Murata; Akihiro Tanemura; Masashi Kishiwada; Hiroyuki Sakurai; Shugo Mizuno; Shuji Isaji
Journal:  BMC Cancer       Date:  2020-05-11       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.